Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years.

× No keyword cloud information.

61 in total

1. Hemostasis Laboratory: Assays for Platelet Function and Von Willebrand Disease.

Authors:
Journal: J Thromb Thrombolysis Date: 1998-09 Impact factor: 2.300

2. Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia.

Authors: Margaret V Ragni; Rachel C Jankowitz; Kristen Jaworski; Elizabeth P Merricks; Mark T Kloos; Timothy C Nichols
Journal: Thromb Haemost Date: 2011-08-11 Impact factor: 5.249

3. In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall.

Authors: Miroslaw Rybaltowski; Yuko Suzuki; Hideo Mogami; Iwona Chlebinska; Tomasz Brzoska; Aki Tanaka; Fumiaki Banno; Toshiyuki Miyata; Tetsumei Urano
Journal: Pflugers Arch Date: 2011-04-15 Impact factor: 3.657

Review 4. [Management of hemostasis disorders after extracorporeal circulation. A clinical therapy algorithm].

Authors: C Jámbor; D Bremerich; A Moritz; E Seifried; B Zwissler
Journal: Anaesthesist Date: 2008-04 Impact factor: 1.041

Review 5. Present and future challanges in the treatment of haemophilia: a clinician's perspective.

Authors: Pier Mannuccio Mannucci; Massimo Franchini
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

6. Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors: Lise J Estcourt; Richard Gregg; Simon Stanworth; Carolyn Doree; Marialena Trivella; Michael F Murphy; Alan Tinmouth
Journal: Cochrane Database Syst Rev Date: 2014

Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years.

1. Hemostasis Laboratory: Assays for Platelet Function and Von Willebrand Disease.

2. Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia.

3. In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall.

Review 4. [Management of hemostasis disorders after extracorporeal circulation. A clinical therapy algorithm].

Review 5. Present and future challanges in the treatment of haemophilia: a clinician's perspective.

6. Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Review 7. Molecular and cellular biology of von Willebrand factor.

Review 8. Perioperative management of the bleeding patient.

Review 9. Effect of Desmopressin on Platelet Dysfunction During Antiplatelet Therapy: A Systematic Review.

10. Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients.